NCT04287062View on ClinicalTrials.gov

Examining the Role of the Orexin System in Sleep and Stress in Persons With Opioid Use Disorder

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Sleep DisturbanceOpioid-use Disorder
Interventions
DRUG

Suvorexant

Dual orexin receptor antagonist

DRUG

Placebos

Weight and color matched placebo

Trial Locations (5)

21014

RECRUITING

Ashley Addiction Treatment, Bel Air

21218

RECRUITING

Man Alive Inc., Lane Treatment Center, Baltimore

21224

RECRUITING

Addiction Treatment Services at Johns Hopkins Bayview Medical Center, Baltimore

RECRUITING

Behavioral Pharmacology Research Unit at the Johns Hopkins Bayview Medical Center, Baltimore

21921

RECRUITING

Ashley Addiction Treatment, Elkton

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Johns Hopkins University

OTHER

NCT04287062 - Examining the Role of the Orexin System in Sleep and Stress in Persons With Opioid Use Disorder | Biotech Hunter | Biotech Hunter